Evaluation of efficacy and safety of targeted therapy and immune checkpoint inhibitors in metastatic colorectal cancer.

World J Gastrointest Oncol · 2025 · PMC12142254 · PMID 40487962

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although the median OS showed a trend toward improvement in the combination group, the difference was insignificant.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

OS non-significance: In all three analyses, OS did not reach statistical significance, though the combination of TT and immunotherapy did show a trend toward longer median OS.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.